<- Go home

Added to YB: 2022-07-08

Pitch date: 2022-07-08

TYME [bullish]

Tyme Technologies, Inc.

+10.77%

current return

Author Info

Special Situation Investments focuses on event-driven trades and low risk arbitrage opportunities with short term catalysts. Sign up for the newsletter.

Company Info

Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States.

Market Cap

$53.5M

Pitch Price

$0.28

Price Target

N/A

Dividend

N/A

EV/EBITDA

1.07

P/E

-2.11

EV/Sales

N/A

Sector

Biotechnology

Category

N/A

Show full summary:
Tyme Technologies (TYME) - Merger Arbitrage - 33% Upside

A summary for this pitch has not been created yet.

Read full article (1 min)